Literature DB >> 2039142

Ophthalmic manifestations of tuberous sclerosis.

D M Robertson1.   

Abstract

The ophthalmic manifestations of tuberous sclerosis include a variety of nonretinal ophthalmic findings which, other than adenoma sebaceum of the lids, are uncommon. Approximately half the patients with tuberous sclerosis have retinal or optic nerve hamartomas; in half of these patients the hamartomas occur bilaterally. Three basic morphologic types of retinal hamartomas are recognized: the most common type is a subtle, relatively flat, smooth-surfaced, salmon-colored, semitransparent, and circular or oval-shaped lesion located in the superficial retina, most commonly near or at the posterior pole. The second type is an easily recognized opaque, white, elevated, multinodular calcified lesion that is frequently described as resembling a mulberry. A third type of lesion contains features of the other two, being calcified and nodular centrally, whereas its perimeter is semitranslucent, smooth, and salmon-colored. The hamartomas may be richly vascularized. They generally do not grow, but over decades some of the lesions may become calcified. Visual loss from retinal and optic nerve hamartomas rarely occurs. Because growth and change of the fundus lesions are rare, treatment is not indicated. Retinoblastoma of the optic nerve and retina is the most important lesion that must be differentiated from the hamartomas seen with tuberous sclerosis.

Entities:  

Mesh:

Year:  1991        PMID: 2039142     DOI: 10.1111/j.1749-6632.1991.tb37744.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  11 in total

1.  Infrared imaging and optical coherence tomography reveal early-stage astrocytic hamartomas not detectable by fundoscopy.

Authors:  Luna Xu; Tomas R Burke; Jonathan P Greenberg; Vinit B Mahajan; Stephen H Tsang
Journal:  Am J Ophthalmol       Date:  2012-02-04       Impact factor: 5.258

2.  A rare case of visual loss due to serous detachment associated with retinal "mulberry" hamartoma in a case of tuberous sclerosis.

Authors:  Jayanta Dutta
Journal:  J Ocul Biol Dis Infor       Date:  2013-03-03

Review 3.  Optical Coherence Tomography of Choroid in Common Neurological Diseases.

Authors:  Federico DI Staso; Marco Ciancaglini; Solmaz Abdolrahimzadeh; Fabian D'Apolito; Gianluca Scuderi
Journal:  In Vivo       Date:  2019 Sep-Oct       Impact factor: 2.155

4.  Ophthalmic manifestations of tuberous sclerosis: a population based study.

Authors:  S A Rowley; F J O'Callaghan; J P Osborne
Journal:  Br J Ophthalmol       Date:  2001-04       Impact factor: 4.638

Review 5.  Tuberous Sclerosis Complex: new criteria for diagnostic work-up and management.

Authors:  Sharon Samueli; Klaus Abraham; Anastasia Dressler; Gudrun Groeppel; Constanze Jonak; Angelika Muehlebner; Daniela Prayer; Andreas Reitner; Martha Feucht
Journal:  Wien Klin Wochenschr       Date:  2015-04-10       Impact factor: 1.704

6.  Aggressive retinal astrocytomas in four patients with tuberous sclerosis complex.

Authors:  Jerry A Shields; Ralph C Eagle; Carol L Shields; Brian P Marr
Journal:  Trans Am Ophthalmol Soc       Date:  2004

7.  The Potpourri of Clinical Signs in Tuberous Sclerosis Complex.

Authors:  Atul Arora; Vipin Rana; Krinjeela Bazgain
Journal:  Ann Indian Acad Neurol       Date:  2020-12-01       Impact factor: 1.383

Review 8.  An Update on the Ophthalmologic Features in the Phakomatoses.

Authors:  Solmaz Abdolrahimzadeh; Andrea Maria Plateroti; Santi Maria Recupero; Alessandro Lambiase
Journal:  J Ophthalmol       Date:  2016-07-17       Impact factor: 1.909

9.  Retinal anaplastic pleomorphic xanthoastrocytoma unassociated with phakomatosis.

Authors:  Roshanak Aliakbar Navahi; Pegah Babaheidarian; Ahad Sedaghat; Masood Naseripour; Gholamhoseyn Aghai; Azam Mardani; Mohammadreza Ahangarani
Journal:  J Curr Ophthalmol       Date:  2018-10-11

10.  Gray lesions in peripheral fundus of a child with epilepsy.

Authors:  Tejaswini Vukkadala; Sanketh Singh Rathod; Shorya Vardhan Azad
Journal:  Indian J Ophthalmol       Date:  2021-01       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.